新型冠状病毒与眼科相关研究进展  

Advances in severe acute respiratory syndrome coronavirus 2 study about ophthalmology

作　　者：丁晓敏 崔彦 DING Xiaomin;CUI Yan(Department of Ophthalmology,Qilu Hospital of Shandong University,Jinan 250012,Shandong,China;The First Clinical College of Shandong University,Jinan 250012,Shandong,China)

机构地区：[1]山东大学齐鲁医院眼科,山东济南250012 [2]山东大学第一临床学院,山东济南250012

出　　处：《山东大学耳鼻喉眼学报》2024年第1期122-127,共6页Journal of Otolaryngology and Ophthalmology of Shandong University

摘　　要：新型冠状病毒感染(corona virus disease 2019,COVID-19)是由严重急性呼吸综合征冠状病毒-2(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)引起的急性感染性肺炎。目前临床已有较多病例报告提示COVID-19患者也可表现出眼部症状,同时在新型冠状病毒疫苗的应用过程中亦出现了各种眼部不良事件。论文通过回顾国内外相关文献及研究,探讨SARS-CoV-2经眼传播的可能性、眼部受累表现、治疗方案以及接种COVID-19疫苗后可能出现的眼部不良事件,并为眼科医务人员的临床防护给出建议。Corona virus disease 2019(COVID-19)is an acute infectious pneumonia caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).Previous reports have suggested that patients with COVID-19 may also exhibit ocular symptoms,and some ophthalmic adverse events have been reported after COVID-19 vaccination.Based on the recent literature and existing studies,this study aims to discuss the possibility of ophthalmic infections due to SARS-CoV-2,the ocular signs,treatments and possible ocular adverse events after COVID-19 vaccination,and provide references to the ophthalmologists for prevention and control.

关 键 词：新型冠状病毒感染 结膜炎 视网膜血管病变 脉络膜 闭角型青光眼 

分 类 号：R77[医药卫生—眼科]